Search Results
Showing 1 of 1 search results for:
A Study of CC-95251, a Monoclonal Antibody Directed Against SIRPĪ±, in Subjects With Advanced Solid and Hematologic Cancers
Status
Condition
Neoplasms
Phase
INTERVENTION
Drug: CC-95251, Drug: Rituximab, Drug: Cetuximab
Eligibility
Ages Eligible for Study :
Sexes Eligible for Study : All
Accepts Healthy Volunteers :
Result 1 of 1